BFRIW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.13% compare to its pairs and should correct upwards.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
Dzisiejszy wolumen	7 410
Średni wolumen	0
Kapitalizacja rynkowa	4.36M
EPS	$-2.88 ( Q1 \| 2024-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300 (Sector) 42.63 (Industry) 30.78
ATR14	$0 (0.00%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2023-07-03	Lanckriet Heikki	Buy	0
2023-05-18	Monaco Erica L.	Buy	76 336	Common Stock
2023-05-18	Monaco Erica L.	Sell	76 336	Restricted Stock Units
2023-05-18	Luebbert Hermann	Buy	95 420	Common Stock
2023-05-18	Luebbert Hermann	Sell	95 420	Restricted Stock Units

INSIDER POWER
15.43
Last 5 transactions
Buy: 271 756 \| Sell: 171 756

Korelacja (AI algo v.1.1b): Undervalued: 0.13% $0.0382 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Biofrontera Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biofrontera Inc. Finanse

Annual	2023
Przychody:	$34.07M
Zysk brutto:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2023
Przychody:	$34.07M
Zysk brutto:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2022
Przychody:	$28.67M
Zysk brutto:	$13.49M (47.04 %)
EPS:	$-0.610

FY	2021
Przychody:	$24.10M
Zysk brutto:	$11.36M (47.13 %)
EPS:	$0

Financial Reports:

No articles found.

Biofrontera Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.